Study of ALXN2050 in Participants With Hepatic Impairment

Clinical trial NCT05259085 · TERMINATED

Trial details

NCT number: NCT05259085
Sponsor: Alexion Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Impaired Hepatic Function Healthy

Start date: 2022-04-07
Primary completion: 2024-08-12
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.